ACADIA PHARMACEUTICALS INC

Ticker: ACAD CUSIP: 004225108 Class: Common Stock

Frazier Life Sciences Management, L.P.'s Holding History (CIK: 0001892134)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,297,198 Value ($000) $34,648 Avg Close $23.90 Range $19.69 - $28.35
Q3 2025
Shares 613,837 Value ($000) $13,099 Avg Close $23.65 Range $20.02 - $26.65
Q1 2025
Shares 470,338 Value ($000) $7,812 Avg Close $18.17 Range $16.28 - $20.68
Q4 2024
Shares 470,338 Value ($000) $8,631 Avg Close $16.14 Range $14.15 - $19.05
Q3 2024
Shares 470,338 Value ($000) $7,234 Avg Close $16.68 Range $15.08 - $19.44
Q2 2024
Shares 470,338 Value ($000) $7,643 Avg Close $16.14 Range $14.55 - $18.63
Q1 2024
Shares 470,338 Value ($000) $8,697 Avg Close $24.78 Range $17.56 - $31.82
Q4 2023
Shares 730,917 Value ($000) $22,885 Avg Close $23.88 Range $20.31 - $32.59
Q3 2023
Shares 630,897 Value ($000) $13,148 Avg Close $27.16 Range $20.54 - $33.99
Q2 2023
Shares 857,338 Value ($000) $20,533 Avg Close $22.23 Range $17.71 - $26.04
Q1 2023
Shares 857,338 Value ($000) $16,135 Avg Close $19.05 Range $15.77 - $21.87
Q4 2022
Shares 857,338 Value ($000) $13,649 Avg Close $15.63 Range $13.73 - $18.78
Q3 2022
Shares 857,338 Value ($000) $14,026 Avg Close $16.19 Range $13.80 - $18.31